首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1485301

兽医眼保健市场规模 - 按产品和服务、动物类型、适应症、最终用途和预测，2024 年 - 2032 年

Veterinary Eye Care Market Size - By Product & Services, Animal Type, Indication, End-use & Forecast, 2024 - 2032

出版日期: 2024年03月14日 | 出版商:

Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3个工作天内

价格

简介目录

随着兽医眼科的进步和专业眼部护理产品的推出，受宠物眼部疾病高发生率的推动，2024 年至 2032 年全球兽医眼部护理市场的复合年增长率将达到 3.5%。由于宠物面临白内障、青光眼和感染等常见疾病，对有效治疗的需求非常大。此外，现代诊断工具和创新疗法的发展提高了护理品质。这为兽医眼保健行业的扩张创造了一个充满希望的前景，满足宠物主人为宠物寻求最佳眼睛健康日益增长的需求。

例如，2024 年 1 月，ENTOD Pharmaceuticals 推出了“FUR”，这是一个为宠物提供眼部和耳部护理药物的部门。 FUR 提供多种兽医解决方案，包括润滑滴剂、抗青光眼药物、抗过敏药物、抗生素及其组合。它反映了人们对宠物保健产品的认识和需求不断增长，表明人们越来越关註解决宠物的特定眼睛和听觉状况。这项发展可以透过提供创新的治疗方法并在更广泛的范围内提高兽医眼部和耳部护理选择的可用性来促进市场成长。

兽医眼保健市场根据产品和服务、动物类型、适应症、最终用途和地区而分散。

由于人们越来越重视猫科动物的健康，特别是它们脆弱的眼睛需求，猫科动物市场将在 2024 年至 2032 年显着扩张。世界各地的猫主人越来越重视全面的眼部护理，从预防措施到先进的治疗。随着猫成为全球流行的宠物，这个细分市场的重要性可能会稳定成长。随着主人与其猫科动物伙伴之间的联繫加强，人们对保持最佳眼睛健康重要性的认识也随之增强，从而使猫科动物成为兽医眼保健行业的关键驱动力。

由于对宠物各种眼部疾病准确、及时诊断的需求不断增长，诊断实验室领域将在 2032 年呈现健康的成长速度。这些专业实验室提供先进的诊断工具和专业知识，帮助兽医精确定位眼部疾病。随着宠物主人对宠物健康的关注度越来越高，对诊断实验室进行彻底眼部检查的依赖也越来越大。诊断实验室在识别和管理眼睛问题方面发挥着至关重要的作用，因此将成为宠物护理行业成长的关键组成部分。

2024年至2032年，亚太地区兽医眼保健市场规模将出现大幅复合年增长率。此外，该地区可支配收入的增加使得宠物医疗保健方面的支出增加。兽医眼科的技术进步也在增强诊断和治疗选择方面发挥了作用。随着越来越多的宠物主人寻求高品质的眼部治疗，亚太地区将成为全球兽医眼部护理行业成长的显着贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 宠物眼部疾病的发生率上升
  - 增加兽医医疗保健支出
  - 全球宠物拥有量增加
  - 兽医眼科的进展
- 产业陷阱与挑战
  - 治疗费用高
  - 缺乏保险保障
成长潜力分析
监管环境
波特的分析
PESTEL分析
定价分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪錶板

第 5 章：市场估计与预测：按产品和服务划分，2018 年 - 2032 年

主要趋势
兽医护理产品
- 诊断
  - 眼压计
  - 眼科测试套件
  - 视网膜电图（ERG）
  - 眼底相机
  - 检眼镜
  - 测厚仪
  - 其他诊断产品
- 治疗
  - 药品
    - 药品类型
    - 抗生素
    - 非类固醇抗发炎药
    - 皮质类固醇
    - 其他药品
    - 依给药途径
    - 口服
    - 专题
    - 可注射
    - 按配销通路
    - 兽医医院药房
    - 零售药局
    - 宠物专卖店
    - 电子商务
  - 镜片
    - 绷带镜片
    - 人工水晶体
  - 雷射设备
兽医护理服务

第 6 章：市场估计与预测：按动物类型，2018 - 2032

主要趋势
犬类
猫科动物
马科
牛科
其他动物类型

第 7 章：市场估计与预测：按指标划分，2018 年 - 2032 年

主要趋势
眼睑异常
白内障
青光眼
视网膜疾病
葡萄膜炎
结膜炎
角膜溃疡
其他适应症

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

主要趋势
兽医院
诊断实验室
其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 10 章：公司简介

An-Vision GmbH
Bausch & Lomb Inc.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
IRIDEX Corporation
I-Med Animal Health
LKC Technologies, Inc.
Neuronix Ltd.
OptoMed
Reichert, Inc.
Zoetis Services LLC

简介目录

Product Code: 8499

Global Veterinary Eye Care Market will register 3.5% CAGR between 2024 and 2032, driven by the high incidence of eye conditions in pets, in line with advancements in veterinary ophthalmology and the introduction of specialized eye care products. With pets facing common ailments like cataracts, glaucoma, and infections, the demand for effective treatments is significant. Furthermore, the development of modern diagnostic tools and innovative treatments enhances the quality of care. This creates a promising landscape for the expansion of the veterinary eye care industry, catering to the increasing needs of pet owners seeking optimal eye health for their companions.

For instance, in January 2024, ENTOD Pharmaceuticals introduced 'FUR,' a division offering eye and ear care medicines for pets. FUR provides a diverse range of veterinary solutions, including lubricating drops, anti-glaucoma medications, anti-allergies, antibiotics, and combinations. It reflects the growing awareness and demand for pet health products, suggesting an increasing focus on addressing specific ocular and aural conditions in pets. This development could contribute to the market growth by offering innovative treatments and enhancing the availability of veterinary eye and ear care options on a broader scale.

The veterinary eye care market is fragmented based on products and services, animal type, indication, end-use, and region.

The feline segment will witness a notable expansion over 2024-2032, fueled by a growing emphasis on feline health, particularly their delicate ocular needs. Cat owners worldwide are increasingly prioritizing comprehensive eye care, from preventive measures to advanced treatments. With cats being popular pets globally, this segment's prominence could grow steadily. As the bond between owners and their feline companions strengthens, so does the recognition of the importance of maintaining optimal eye health, making the feline segment a key driver in the veterinary eye care industry.

The diagnostic laboratories segment will exhibit a healthy growth rate through 2032, propelled by the increasing demand for accurate and timely diagnoses of various eye conditions in pets. These specialized laboratories offer advanced diagnostic tools and expertise, aiding veterinarians in pinpointing ocular diseases with precision. As pet owners become more proactive about their pets' health, the reliance on diagnostic laboratories for thorough eye examinations grows. With their crucial role in identifying and managing eye issues, the diagnostic laboratories segment will emerge as a pivotal component of the pet care industry's growth.

Asia Pacific veterinary eye care market size will experience a substantial CAGR from 2024 to 2032. Rapid urbanization, increasing pet adoption rates, and a growing awareness of animal health drive this trend. Moreover, the region's rising disposable incomes allow for greater spending on pet healthcare. Technological advancements in veterinary ophthalmology also play a role in enhancing diagnosis and treatment options. With an increasing number of pet owners seeking high-quality eye treatments, the Asia Pacific region will stand as a remarkable contributor to the global veterinary eye care industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of eye disorders in pets
  - 3.2.1.2 Increasing veterinary healthcare expenditure
  - 3.2.1.3 Increasing pet ownership globally
  - 3.2.1.4 Advancements in veterinary ophthalmology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Lack of insurance coverage
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis
3.7 Pricing analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product & Services, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Veterinary care products
- 5.2.1 Diagnosis
  - 5.2.1.1 Tonometer
  - 5.2.1.2 Ophthalmic test kits
  - 5.2.1.3 Electroretinogram (ERG)
  - 5.2.1.4 Fundus camera
  - 5.2.1.5 Ophthalmoscope
  - 5.2.1.6 Pachymeter
  - 5.2.1.7 Other diagnostic products
- 5.2.2 Treatment
  - 5.2.2.1 Drugs
    - 5.2.2.1.1 Drug type
    - 5.2.2.1.1.1 Antibiotics
    - 5.2.2.1.1.2 NSAIDs
    - 5.2.2.1.1.3 Corticosteroids
    - 5.2.2.1.1.4 Other drugs
    - 5.2.2.1.2 By route of administration
    - 5.2.2.1.2.1 Oral
    - 5.2.2.1.2.2 Topical
    - 5.2.2.1.2.3 Injectable
    - 5.2.2.1.3 By distribution channel
    - 5.2.2.1.3.1 Veterinary hospitals pharmacies
    - 5.2.2.1.3.2 Retail drug stores
    - 5.2.2.1.3.3 Pet specialty stores
    - 5.2.2.1.3.4 E-commerce
  - 5.2.2.2 Lenses
    - 5.2.2.2.1 Bandage lenses
    - 5.2.2.2.2 Intraocular lenses
  - 5.2.2.3 Laser devices
5.3 Veterinary care services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Canine
6.3 Feline
6.4 Equine
6.5 Bovine
6.6 Other animal type

Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Eyelid abnormalities
7.3 Cataract
7.4 Glaucoma
7.5 Retinal disorders
7.6 Uveitis
7.7 Conjunctivitis
7.8 Corneal ulcers
7.9 Other indications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Veterinary hospitals
8.3 Diagnostic laboratories
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa